Drug Shortage Report for VIDEX EC
| Report ID | 11840 |
| Drug Identification Number | 02244598 |
| Brand name | VIDEX EC |
| Common or Proper name | Didanosine |
| Company Name | BRISTOL-MYERS SQUIBB CANADA |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DIDANOSINE |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE (ENTERIC-COATED) |
| Route of administration | ORAL |
| Packaging size | 1 BTL X 30 |
| ATC code | J05AF |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2017-07-10 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2017-07-04 |
| Shortage status | Avoided shortage |
| Updated date | 2017-07-04 |
| Company comments | Stock is now available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
| Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2017-07-04 | English | Compare |
| v6 | 2017-07-04 | French | Compare |
| v5 | 2017-07-04 | English | Compare |
| v4 | 2017-07-04 | English | Compare |
| v3 | 2017-07-01 | English | Compare |
| v2 | 2017-06-05 | French | Compare |
| v1 | 2017-06-05 | English | Compare |
Showing 1 to 7 of 7